Join to access to all OVN content. Join for Free
How Will AI and Machine Learning Affect the MSL
AI in Medical Affairs Transformative Role of AI AI for MSLs AI in Healthcare AI and Job Seekers

How Will AI and Machine Learning Affect the MSL


Share This Article


Summary

In this episode, Tom Caravela is joined by Dr. Sanjay Singhvi to delve into the transformative role of AI in medical affairs. They discuss AI's ability to address industry challenges, its practical applications for MSLs, and its impact on decision-making processes. The conversation extends to AI's utility for managers in trend analysis and resource allocation. They also explore how AI can benefit job seekers and entry-level MSLs, particularly in resume optimization and interview preparation. The episode wraps up with insights into current industry trends and a reflection on AI's limitations, concluding with sponsor acknowledgments and closing remarks.

Dr Sanjay Singhvi, Director at VMLY&R Health discusses how artificial intelligence and machine learning will affect the role of the MSL.

This episode is sponsored by the Digital Solutions division at VMLY&R Health. **VMLY&R Health is a global agency united around a single purpose: improving health all over the world by making science meaningful. For more details about their innovative technology solutions designed specifically for Medical Affairs, please visit https://www.vmlyr.com/health/digitalsolutions

Click for Source
AI in Medical Affairs, Transformative Role of AI, AI for MSLs, AI in Healthcare, AI and Job Seekers

Related Topics

Meet Our Innovation Partners

Loading partners...

You May Also Like

Article
Empowering people to drive medical affairs performance with AI
Partner Avatar Envision Pharma Group

Empowering people to drive medical affairs performance with AI

Podcast
The Struggle With KOL Access in Todays World
Partner Avatar MSL Talk: Tom Caravela, Carsten Schnatwinkel, Jeanna Cooper

The Struggle With KOL Access in Todays World

Podcast
How Medical Affairs Professionals Should Engage with Digital Opinion Leaders
Partner Avatar MSL Talk: Tom Caravela, Paul Ward

How Medical Affairs Professionals Should Engage with Digital Opinion Leaders

Article
Methodological and reporting standards for quality-of-life data eligible for European Society for Medical Oncology-Magnitude of Clinical Benefit Scale
OVN Avatar S.F. Oosting, J. Barriuso, A. Bottomley, M. Galotti, B. Gyawali, B. Kiesewetter, N.J. Latino, F. Martinelli, M. Pe, G. Pentheroudakis, F. Roitberg, H. Vachon, E.G.E. de Vries, M. Piccart, N.I. Cherny

Methodological and reporting standards for quality-of-life data eligible for European Society for Medical Oncology-Magnitude of Clinical Benefit Scale

Article
Sponsorship of oncology clinical trials in the United States according to age of eligibility
OVN Avatar Dylan V Neel, David S Shulman, Clement Ma, Florence Bourgeois, Steven G DuBois

Sponsorship of oncology clinical trials in the United States according to age of eligibility

Article
Model-Informed Therapeutic Dose Optimization Strategies for Antibody-Drug Conjugates in Oncology: What Can We Learn From US Food and Drug Administration-Approved Antibody-Drug Conjugates?
OVN Avatar Michael Z. Liao, Dan Lu, Matts Kågedal, Dale Miles, Divya Samineni, Stephanie N. Liu, Chunze Li

Model-Informed Therapeutic Dose Optimization Strategies for Antibody-Drug Conjugates in Oncology: What Can We Learn From US Food and Drug Administration-Approved Antibody-Drug Conjugates?

Explore OVN